
Faculdade de Medicina
Articles
-
1 month ago |
academic.oup.com | Faculdade de Medicina |Universidade de Lisboa |Jose Antonio |José Antonio
This Spot the Diagnosis article refers to ‘Answer: Diagnostic dilemma in a critical extracorporeal membrane oxygenation patient: a case of uncertain aortic pathology’, by C. Gregório et al. https://doi.org/10.1093/ehjacc/zuaf016. A 56-year-old male experienced an episode of chest pain followed by cardiopulmonary arrest (CPA) upon arrival of the pre-hospital emergency team.
External Validation of the Walter Index for Posthospitalization Mortality Prediction in Older Adults
Jan 22, 2025 |
jamanetwork.com | Thiago J. Avelino-Silva |Servico de Geriatria |Faculdade de Medicina
Key PointsQuestion Does the Walter Index, developed in the US to assess 12-month mortality risk among hospitalized older adults, predict posthospitalization mortality in older adults outside the US? Findings In this prognostic study of 2780 adults aged 70 years or older in Brazil, the Walter Index demonstrated predictive accuracy for 12-month mortality comparable to that in the original US cohort.
-
Nov 25, 2024 |
academic.oup.com | Faculdade de Medicina |Universidade Católica Portuguesa
The European Society of Endocrinology (ESE) and the Union Européenne des Médecins Spécialistes (U.E.M.S.) Section and Board of Endocrinology have produced a Curriculum and Training Recommendation in Endocrinology to provide updated recommendations concerning the content and structure of postgraduate training.
-
Oct 8, 2024 |
jamanetwork.com | Servico de Geriatria |Faculdade de Medicina |Thiago J. Avelino-Silva
Early detection of cognitive impairment is a critical public health concern, directly affecting the quality of care and life for millions of older adults. Globally, approximately 57 million people live with dementia, including an estimated 6.7 million US individuals aged 65 years or older with Alzheimer disease.1 As life expectancy increases, the prevalence of dementia is expected to double by 2050, emphasizing the urgent need for early detection strategies.
-
Sep 2, 2024 |
academic.oup.com | Faculdade de Medicina |Rheumatology Unit
To assess the impact of baseline rheumatoid factor (RF) level on drug concentrations and efficacy of certolizumab pegol (CZP; tumour necrosis factor inhibitor [TNFi] without a crystallisable fragment [Fc]) and adalimumab (ADA; Fc-containing TNFi) in patients with rheumatoid arthritis (RA). The phase 4 EXXELERATE study (NCT01500278) was a 104-week, randomised, single-blind (double-blind until week 12; investigator-blind thereafter), head-to-head study of CZP vs ADA in patients with RA.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →